US stock indices ended mixed on Tuesday, with clear evidence of portfolio rebalancing as the second half of 2025 began. Investors cashed in on winning tech/growth stocks and used the proceeds to increase their exposure to ‘value’ stocks and other overlooked (and undervalued) corners of the market.
This led to gains of 0.9% and 1.0% for the Dow and the mid-cap, domestically focused Russell 2000, respectively. Within the Dow, demand was notably high for health care and materials names like Amgen, Johnson & Johnson, and UnitedHealth. Meanwhile, the tech-heavy indices, the S&P 500 and NASDAQ, dropped 0.1% and 0.8%, respectively.
The rotation followed weakness in the information technology and communications services sectors, both of which fell by over 1%. Key names like Nvidia, Palantir and AMD all came under selling pressure. Tesla dropped over 5%, falling back toward the $300 level ahead of its Q2 deliveries report due today.
Despite this, the US 500 triggered its first “golden cross” in over two years. This is a technical signal which is typically viewed as bullish and occurs when the 50-day moving average crosses above the 200-day moving average, as seen below:

Source: TN Trader
Historically, such a pattern has been associated with longer-term market resilience. The last time such an indicator appeared was back in February 2023. The index has rallied more than 48% since.